Chengxin Luo

509 total citations
23 papers, 363 citations indexed

About

Chengxin Luo is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Chengxin Luo has authored 23 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 11 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Chengxin Luo's work include Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Chengxin Luo is often cited by papers focused on Hematopoietic Stem Cell Transplantation (9 papers), Acute Myeloid Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Chengxin Luo collaborates with scholars based in China, United States and Pakistan. Chengxin Luo's co-authors include Hu Zhang, Zhen Yu, Shuangnian Xu, Zhu‐Jun Wang, Xi Li, Jieping Chen, Guixian Wu, Min Zhu, Yanni Ma and Zhen Huang and has published in prestigious journals such as Blood, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Chengxin Luo

22 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengxin Luo China 10 119 98 89 76 61 23 363
Geom-Seog Seo South Korea 10 100 0.8× 56 0.6× 99 1.1× 42 0.6× 40 0.7× 25 363
Xingkui Xue China 10 176 1.5× 89 0.9× 76 0.9× 76 1.0× 69 1.1× 19 335
Daiana Giannini Italy 4 160 1.3× 80 0.8× 108 1.2× 20 0.3× 68 1.1× 7 500
Nicole Hannemann Germany 10 190 1.6× 60 0.6× 163 1.8× 28 0.4× 47 0.8× 15 437
Anna Brandt Germany 9 138 1.2× 243 2.5× 109 1.2× 57 0.8× 99 1.6× 17 470
Kory J. Engelke United States 10 202 1.7× 85 0.9× 93 1.0× 22 0.3× 106 1.7× 16 476
Yinhong Song China 12 192 1.6× 54 0.6× 139 1.6× 39 0.5× 33 0.5× 29 426
Jia Gu China 12 184 1.5× 116 1.2× 99 1.1× 26 0.3× 63 1.0× 33 428
Jeanette Osban United States 9 202 1.7× 51 0.5× 244 2.7× 48 0.6× 87 1.4× 9 552
Sen Zhang China 10 140 1.2× 62 0.6× 121 1.4× 17 0.2× 70 1.1× 33 364

Countries citing papers authored by Chengxin Luo

Since Specialization
Citations

This map shows the geographic impact of Chengxin Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxin Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxin Luo more than expected).

Fields of papers citing papers by Chengxin Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengxin Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxin Luo. The network helps show where Chengxin Luo may publish in the future.

Co-authorship network of co-authors of Chengxin Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Chengxin Luo. A scholar is included among the top collaborators of Chengxin Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxin Luo. Chengxin Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Luo, Chengxin, Wei Ling, Guixian Wu, et al.. (2023). Second-line therapy for patients with steroid-refractory aGVHD: systematic review and meta-analysis of randomized controlled trials. Frontiers in Immunology. 14. 1211171–1211171. 4 indexed citations
4.
Luo, Chengxin, Guixian Wu, Zhen Huang, et al.. (2023). Effects of donor-specific antibodies on engraftment and long-term survival after allogeneic hematopoietic stem cell transplantation—A systematic review and meta-analysis. Bone Marrow Transplantation. 58(5). 544–551. 6 indexed citations
5.
6.
Luo, Chengxin, Guixian Wu, Yali Zhang, et al.. (2022). Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials. Stem Cell Research & Therapy. 13(1). 123–123. 11 indexed citations
7.
Li, Wei, et al.. (2022). Flood Hazard Analysis Based on Copula Connect Function. Natural Hazards Review. 24(1). 3 indexed citations
8.
Luo, Chengxin, Guixian Wu, Yanni Ma, et al.. (2021). Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20+ B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis. Scientific Reports. 11(1). 3255–3255. 40 indexed citations
9.
Zhang, Yali, Yanni Ma, Guixian Wu, et al.. (2021). SENP1 promotes MCL pathogenesis through regulating JAK-STAT5 pathway and SOCS2 expression. Cell Death Discovery. 7(1). 192–192. 9 indexed citations
10.
Li, Teng, Chengxin Luo, Jiasi Zhang, et al.. (2021). Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Stem Cell Research & Therapy. 12(1). 246–246. 32 indexed citations
11.
Sun, Yanni, Jia Wan, Chengxin Luo, et al.. (2021). Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non‐M3 Acute Myeloid Leukemia. BioMed Research International. 2021(1). 1929357–1929357. 5 indexed citations
12.
Luo, Chengxin, Li Wang, Guixian Wu, et al.. (2021). Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies. Stem Cell Research & Therapy. 12(1). 310–310. 9 indexed citations
13.
Luo, Chengxin, Qingrong Li, Xi Li, et al.. (2021). Prognostic Role of Serum Albumin Level in Patients with Lymphoma Undergoing Autologous Stem Cell Transplantation. Annals of Transplantation. 26. e933365–e933365. 4 indexed citations
14.
Zhang, Yali, Shuangnian Xu, Zhe Chen, et al.. (2020). Zfp521 SUMOylation facilities erythroid hematopoietic reconstitution under stress. Bioscience Biotechnology and Biochemistry. 84(5). 943–953. 2 indexed citations
15.
Luo, Chengxin, Zhonghui Wen, Zhen Yu, et al.. (2018). Chinese research into severe ulcerative colitis has increased in quantity and complexity. World Journal of Clinical Cases. 6(3). 35–43. 14 indexed citations
16.
Wang, Zhu‐Jun, Min Zhu, Chengxin Luo, et al.. (2018). High level of IgG4 as a biomarker for a new subset of inflammatory bowel disease. Scientific Reports. 8(1). 10018–10018. 17 indexed citations
17.
Yu, Zhen, Chengxin Luo, & Hu Zhang. (2018). Early detection of ulcerative colitis-associated colorectal cancer. Gastroenterology report. 6(2). 83–92. 35 indexed citations
18.
Wang, Zhu‐Jun, Wenyan Zhang, Chengxin Luo, et al.. (2018). Primary Intestinal Epstein–Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 12(8). 896–904. 12 indexed citations
19.
Luo, Chengxin, et al.. (2017). Upregulation of the transient receptor potential vanilloid 1 in colonic epithelium of patients with active inflammatory bowel disease.. PubMed. 10(11). 11335–11344. 25 indexed citations
20.
Luo, Chengxin & Hu Zhang. (2017). The Role of Proinflammatory Pathways in the Pathogenesis of Colitis-Associated Colorectal Cancer. Mediators of Inflammation. 2017. 1–8. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geom-Seog Seo Breakdown of academic impact, for papers by Xingkui Xue Breakdown of academic impact, for papers by Daiana Giannini Breakdown of academic impact, for papers by Nicole Hannemann Breakdown of academic impact, for papers by Anna Brandt Breakdown of academic impact, for papers by Kory J. Engelke Breakdown of academic impact, for papers by Yinhong Song Breakdown of academic impact, for papers by Jia Gu Breakdown of academic impact, for papers by Jeanette Osban Breakdown of academic impact, for papers by Sen Zhang
Rankless by CCL
2026